|Published||Report Code||Available Format||Pages|
Saudi Arabia Microbiology Cell Culture Market Overview
The Saudi Arabian microbiology cell culture market is estimated to be valued at $29.8 million in 2017 and is projected to grow at a CAGR of 4.5% during the forecast period. Based on product, the market has been categorized into consumables and instruments. Instruments are further classified into bioreactors, cell culture vessels, cell culture storage equipment and cell culture supporting equipment. Bioreactors are further classified into conventional and single-use bioreactors, where conventional bioreactors are estimated to hold a larger share in the microbiology cell culture bioreactors market, due to their wide application in hospitals, clinics, academic institutes and research laboratories.
SAUDI ARABIA MICROBIOLOGY CELL CULTURE SUPPORTING EQUIPMENT MARKET, BY TYPE, $'000 (2013-2023)
On the basis of type of microbiology cell culture storage equipment, the Saudi Arabian market is classified into refrigerators and freezers, and cryostorage systems. Refrigerators and freezers are estimated to hold a larger share in the Saudi Arabian microbiology cell culture storage equipment market. Cryostorage systems are expected to grow at a faster CAGR of 5.1% during the forecast period.
On the basis of type of microbiology cell culture supporting equipment, the Saudi Arabian market is classified into cell counters, filtration systems, centrifuges, CO2 incubators, autoclaves, microscopes, biosafety cabinets, and other supporting equipment. Biosafety cabinets are expected to witness the fastest growth, with a CAGR of 4.9%, in the forecast period, as these are highly effective in reducing the risk of contamination during cell culture. On the basis of culture type, the Saudi Arabian microbiology cell culture market is categorized into bacterial and eukaryotic cell cultures, where bacterial cell cultures are expected to grow at a faster CAGR of 5.0% during the forecast period.
Based on end user, the microbiology cell culture market in Saudi Arabia is categorized into food and beverage companies, pharmaceutical and biotechnology companies, academic and research institutes and other end users. Pharmaceutical and biotechnology companies registered largest share in the Saudi Arabian market, whereas academic and research institutes are projected to grow a the fastest CAGR of 5.1% during the forecast period.
Saudi Arabia Microbiology Cell Culture Market Dynamics
The microbiology cell culture market in Saudi Arabia has witnessed an emerging trend of automation in microbiology, that aids in meeting the challenges of growing necessity for faster turnaround and increased test volumes in microbiology laboratories. The adoption of computer technology in laboratories, and application of laboratory interface systems (LIS) allow use of minimal sample volumes for accurate results. According to a study published in NCBI in 2014, researchers made use of MALDI-TOF MS for identification of new bacteria species in air samples from Makka, Saudi Arabia, during the Hajj. It has been noted that during the Hajj, an increase in the incidence of respiratory tract infections, continues to exert burden on the pilgrims.
Some of the major factors contributing to the growth of the microbiology cell culture industry in Saudi Arabia are the growing healthcare expenditure, thriving life sciences sector and surging geriatric population. Growth in the life sciences sector of any country is majorly attributed to the country’s economic strength and healthcare spending level. In 2016, King Abdulaziz City for Science and Technology (KACST) spent $373.0 million on health biotechnology research projects under the National Science, Technology and Innovation Plan (NSTIP) to study certain rare conditions in the region and for the diagnosis and treatment of both communicable and non-communicable diseases.
The untapped market in emerging economies is a key factor providing growth opportunities to the players in the microbiology cell culture market in Saudi Arabia. The life sciences and pharmaceutical industries are undergoing a rapid transformation in various emerging economies, including Saudi Arabia. The country’s trade paradigm is shifting its focus toward economic diversification and creation of job opportunities by limiting the export and shipping of pharmaceutical products. The major factors promoting the growth of the market are growing population, increasing per capita spending on healthcare services, and rising propensity toward the purchase of expensive patented products.
Saudi Arabia Microbiology Cell Culture Market Competitive Landscape
The top three players held an estimated share of more than 60.0% in the microbiology cell culture market 2017. Merck KGaA held the second largest share in the Saudi Arabian market, with an estimated contribution of 21.5% in 2017 and revenue of $6.4 million in the same year. This market share of the company is majorly attributed to its strong customer base, with respect to the brand image which has helped it in securing a competitive position in the market.
Some of the major players operating in the microbiology cell culture market in Saudi Arabia are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, bioMérieux S.A., Scharlab S.L., Hardy Diagnostics, Sara Medical Supplies Factory, Medical Disposable Manufacturing Company (MDM), Saudi Prepared Media Laboratory Limited Company, Diamond Microscope Est., and General Electric Company.